| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/06/2008 | EP1516061B1 Method for identifying agonists or antagonists for the gpr45-like/gpr63 receptor |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1476149B1 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 08/06/2008 | EP1432714B1 Chemical compounds |
| 08/06/2008 | EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 08/06/2008 | EP1385523B1 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment |
| 08/06/2008 | EP1385518B1 Benzimidazolone compounds |
| 08/06/2008 | EP1377671B1 Oncolytic adenoviral vectors |
| 08/06/2008 | EP1328515B1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | EP1257819B1 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1236712B1 Amidinophenylpyruvic acid derivative |
| 08/06/2008 | EP1192277B1 Diagnosis of restenosis |
| 08/06/2008 | CN101237885A Agent for regeneration and/or protection of nerves |
| 08/06/2008 | CN101237880A Methods of treating diseases with a VEGF antagonist |
| 08/06/2008 | CN101237869A Pyridone derivatives for modulating stress-activated protein kinase system |
| 08/06/2008 | CN101237868A Nanoparticulate clopidogrel and aspirin combination formulations |
| 08/06/2008 | CN101237780A Delivery systems |
| 08/06/2008 | CN101235027A Xanthiphenylketamine crystal and its preparation method and medical use |
| 08/06/2008 | CN101235020A Substituted cinnamamide derivatives and application of the same as nerve protecting agent |
| 08/06/2008 | CN101235004A Omega-amidosulphonic acid substituted hypocrellin derivatives, preparation method and application thereof |
| 08/06/2008 | CN101234189A Chinese medicine composition for preventing and treating cardiovascular inflammation (toxin) |
| 08/06/2008 | CN101234175A Chinese medicine thrombolysis paralysis-treating granule for treating acute cerebral infarction |
| 08/06/2008 | CN101234171A Health product with blood fat lowering and preventing and treating cardio-cerebralvascular disease function and preparation thereof |
| 08/06/2008 | CN101234170A Sanweishengmai injection and preparation thereof |
| 08/06/2008 | CN101234169A Application of Chinese medicine composition in preparing medicament for adjusting cardiac muscle cell potassium ion channel |
| 08/06/2008 | CN101234137A Drug for curing coronary disease |
| 08/06/2008 | CN101234133A Technique for using tribulus whole grass to extract total saponins of tribulus |
| 08/06/2008 | CN101234129A Application of compound composition in preparing medicaments for treating cardiovascular and cerebrovascular diseases |
| 08/06/2008 | CN101234123A Application of certain concentration hydrochloric acid water for treating blood vessel disease |
| 08/06/2008 | CN101234120A Notoginseng dropping pills and preparation method thereof |
| 08/06/2008 | CN101234118A Medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 08/06/2008 | CN101234109A Pharmaceutical composition containing (3R, 2í»S)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |
| 08/06/2008 | CN101234108A Pharmaceutical composition containing (3S, 2í»R)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |
| 08/06/2008 | CN101234107A Pharmaceutical composition containing (3S, 2í»S)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |
| 08/06/2008 | CN101234106A Use of imidazolone compounds for treating cardiovascular and cerebrovascular diseases |
| 08/06/2008 | CN101234102A Peperphentonamine hydrochloride freeze-dried injection and preparation and application thereof |
| 08/06/2008 | CN101234101A Medicine for preventing and/or treating obesity |
| 08/06/2008 | CN101234089A Alkaline fibroblast growth factor liposome vaccine and preparation method and application thereof |
| 08/06/2008 | CN101233885A Health tea |
| 08/06/2008 | CN101233884A Method for preparing bead type gynostemma pentaphylla health-care tea |
| 08/06/2008 | CN100408581C 3-(1-alkoxy ethyl)-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid, its synthetic method and light power therapeutic medicine |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/06/2008 | CN100408101C Gene therapy for critical limb ischemia with wild type or mutant eNOS |
| 08/06/2008 | CN100408099C Oral pharmaceutical composition containing a block copolymer |
| 08/06/2008 | CN100408093C Use of inhibitor of angiotonin converzyme in preparing pharmaceutical formulations for prevention of stroke, diabetes and/or congestive heart failure |
| 08/06/2008 | CN100408092C Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 08/06/2008 | CN100408074C Chinese traditional medicine for treating diseases of high blood pressure, cerebral arteriosclerosis, cerebral infarction, cerebral thrombosis, cerebral hemorrhage and brain atrophy and preparation me |
| 08/06/2008 | CN100408066C Preparing process and product of Chinese medicine dripping pill with tea extract |
| 08/06/2008 | CN100408052C Medicine composition for treating chronic heart failure and hypotension and its preparation and use |
| 08/06/2008 | CN100408047C Medicinal composition of fructose diphosphate sodium and magnesium salt |
| 08/06/2008 | CN100408045C Medicinal composition for treating cardio-cerebro-vascular diseases |
| 08/06/2008 | CN100408043C Medicinal composition containing polydatin and its use |
| 08/06/2008 | CN100408035C Use of valsartan or its metabolite to inhibit platelet aggregation |
| 08/06/2008 | CN100408033C Fat emulsion of biobalide B and preparation method |
| 08/05/2008 | US7408064 Neuropeptide y5 antagonist; therapy for eating disorders |
| 08/05/2008 | US7408036 Human voltage gated sodium channel β1A subunit and methods of use |
| 08/05/2008 | US7408024 Somatostatin antagonists |
| 08/05/2008 | US7408021 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407963 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 08/05/2008 | US7407962 Heteroaryl compounds useful as inhibitors or protein kinases |
| 08/05/2008 | US7407954 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/05/2008 | US7407943 Comprises oligonucleotide which targets apolipoprotein nucleotide sequences and prevents expression; gene expresion inhibition; diagnosis and treatment of cardiovascular, infectious, hyperlipidemic and atherosclerotic disorders |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407938 1,4-Diphenyl-3-(3-hydroxy-3-phenylpropyl)-2-azetidinones, e.g., 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-y]lbenzylcarbamoyl}phenoxy)benzoic acid; antilipemic agents that have intestinal absorption of less than 10%, |
| 08/05/2008 | US7407767 Treating dilated cardiomyopathy by removing anti-cardiac troponin autoantibody from patient's blood |
| 08/05/2008 | US7407676 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 08/05/2008 | US7407649 Silicon compounds and their use |
| 08/05/2008 | US7407475 Modified annexin proteins, and methods and compositions for using them |
| 08/05/2008 | CA2404152C Inhibition of cyclooxygenase-2 activity |
| 08/05/2008 | CA2388470C Use of carbonylamino derivatives against cns disorders |
| 08/05/2008 | CA2353808C Agent for lowering endothelin levels |
| 08/05/2008 | CA2343575C Inhibition of smooth muscle cell migration by heme oxygenase 1 |
| 08/05/2008 | CA2334577C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/05/2008 | CA2290622C Selective thyroid hormone analogs |
| 08/05/2008 | CA2223595C Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 08/05/2008 | CA2176649C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 08/05/2008 | CA2137378C D-enzyme compositions and methods of their use |
| 07/31/2008 | WO2008091618A1 Use of d-ribose to treat cardiac arrhythmias |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090857A1 COMPOUND, α1 ADRENALINE RECEPTOR ANTAGONIST, AND COMPOSITION |
| 07/31/2008 | WO2008090678A1 Novel peptide |
| 07/31/2008 | WO2008090198A1 Use of mtp inhibitors for increasing levels of satiety hormones |
| 07/31/2008 | WO2008089549A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 07/31/2008 | WO2008075978A3 An extract |
| 07/31/2008 | WO2008069688A3 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 07/31/2008 | WO2008063867A3 Tetrahydrocyclopenta[b] indole compounds as androgen receptor modulators |
| 07/31/2008 | WO2008055711A3 Use of an adenosine antagonist |
| 07/31/2008 | WO2008051795A3 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 07/31/2008 | WO2008036216A8 Piperidine derivatives as renin inhibitors |
| 07/31/2008 | WO2008031061A3 Anti-activin a antibodies and uses thereof |
| 07/31/2008 | WO2008004119A3 Eugenia jambolana plant extracts for treating osteoporosis and the extraction process thereof |
| 07/31/2008 | WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/31/2008 | US20080184381 Schizophrenia-related voltage-gated ion channel gene and protein |
| 07/31/2008 | US20080183003 Neuroprotective agents; nitrate-functional, for example 1-amino-3,5-dimethyl-7-nitrateadamantane hydrochloride |